Company intelligence / Profile preview
Dong-A ST
Seoul, SOUTH KOREArnd.donga-st.com ↗
- Ownership
- Public · 170900
- Development stage
- Commercial
01
Overview
Dong-A ST is a leading South Korean pharmaceutical and biotech company with a strong focus on small molecule drugs, biosimilars, and biologics. The company has several approved products in major indications such as diabetes, erectile dysfunction, prostatic hyperplasia, growth disorders, and bacterial infections. It invests heavily in R&D and is expanding into oncology and immune disease therapeutics through partnerships. Its pipeline includes both proprietary novel drugs and biosimilars; key marketed products include Evogliptin Tartrate for diabetes, Udenafil for erectile dysfunction, Naftopidil for prostatic hyperplasia, Somatropin biosimilar for growth disorders in children, and Tedizolid Phosphate for bacterial infections[1][4][5][8].
- Therapeutic areas
- GastroenterologyMen's HealthEndocrinologyInfectious Diseases
- Modalities
- Small moleculesBiosimilarsAntibody drug conjugates (ADCs)Chemical drugsBiologics
- Industry
- Biotech
02
Drug pipeline
60 assets59 more assets in the full pipeline.
03
Partnerships
Includes collaborations with domestic/international partners to expand into biopharmaceuticals/gene therapyNeuroBo Pharmaceuticals is an investor/collaborator
04
Financials
- Market cap
- $240.3M
- Total revenue
- $597.5M
- Enterprise value
- $443.1M
Beyond the preview
Go deeper on Dong-A ST.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dong-A ST.